BVF INC/IL

CIK

1056807

City

San Francisco

State / Country

CA

Stock

XNCR — Xencor Inc

Top Portfolio Positions

40 positions · $3,136,560,615 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
KYMR	Kymera Therapeutics, Inc. Healthcare	5,502,710	$458,320,715	14.61%
MLTX	MoonLake Immunotherapeutics Healthcare	16,001,284	$298,263,933	9.51%
RVMD	Revolution Medicines, Inc. Healthcare	2,856,782	$277,822,049	8.86%
NKTR	Nektar Therapeutics Healthcare	2,559,595	$184,162,860	5.87%
GPCR	Structure Therapeutics Inc. Healthcare	3,459,358	$166,741,055	5.32%
MIRM	Mirum Pharmaceuticals, Inc. Healthcare	1,584,727	$146,397,080	4.67%
GHRS	GH Research PLC Healthcare	8,650,158	$121,621,221	3.88%
PVLA	Palvella Therapeutics, Inc. Healthcare	960,989	$119,787,278	3.82%
ZYME	Zymeworks Inc. Healthcare	3,734,142	$93,502,915	2.98%
XNCR	Xencor Inc Healthcare	7,133,720	$86,032,663	2.74%

Portfolio Trend

25 quarters · across all stocks

Holdings in XNCR

Compact Export CSV

Shares Held

Position Value (USD)

11 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$86,032,663	7,133,720	0.0%	Shares	Defined	2026-05-15
2025-12-31	$109,217,253	7,133,720	+160.3%	Shares	Defined	2026-02-17
2025-09-30	$32,141,853	2,740,141	0.0%	Shares	Defined	2025-11-14
2025-06-30	$21,537,508	2,740,141	0.0%	Shares	Defined	2025-08-14
2025-03-31	$29,155,100	2,740,141	+19.7%	Shares	Defined	2025-05-15
2024-12-31	$52,595,704	2,288,760	+169.3%	Shares	Defined	2025-02-14
2024-09-30	$17,093,500	850,000	-32.8%	Shares	Defined	2024-11-14
2020-12-31	$55,181,217	1,264,754	-38.8%	Shares	Defined	2021-02-12
2020-09-30	$80,221,521	2,068,098	0.0%	Shares	Defined	2020-11-13
2020-06-30	$66,985,694	2,068,098	+22.4%	Shares	Defined	2020-08-14
2020-03-31	$50,476,284	1,689,300	—	Shares	Defined	2020-05-15
No 13F history on record for this holder in this stock.